Table of Contents Author Guidelines Submit a Manuscript
Schizophrenia Research and Treatment
Volume 2017, Article ID 6120970, 8 pages
https://doi.org/10.1155/2017/6120970
Research Article

Impact of Pharmacist Counselling on Clozapine Knowledge

1Pharmacy Department, St. Patrick’s University Hospital, James St., Dublin 8, Ireland
2Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, Cavanagh Pharmacy Building, Cork, Ireland
3Department of Pharmacy, Mercy University Hospital, Grenville Place, Cork, Ireland

Correspondence should be addressed to Ciara Ní Dhubhlaing; moc.liamstapts@gnialhbuhdinc

Received 25 January 2017; Revised 4 May 2017; Accepted 16 May 2017; Published 13 June 2017

Academic Editor: Luis San

Copyright © 2017 Ciara Ní Dhubhlaing et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Novartis UK, “Clozaril Summary of Product Characteristics,” 2015, http://www.medicines.ie.
  2. D. M. Taylor, “Clozapine for treatment-resistant Schizophrenia: still the gold standard?” CNS Drugs, vol. 31, no. 3, pp. 177–180, 2017. View at Publisher · View at Google Scholar
  3. M. R. Schmitt, M. J. Miller, D. L. Harrison et al., “Communicating non-steroidal anti-inflammatory drug risks: verbal counseling, written medicine information, and patients’ risk awareness,” Patient Education and Counseling, vol. 83, no. 3, pp. 391–397, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. C. S. Racey, W. Zhang, E. K. Brandson et al., “HIV antiviral drug resistance: patient comprehension,” AIDS Care, vol. 22, no. 7, pp. 816–826, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Macpherson, B. Jerrom, and A. Hughes, “A controlled study of education about drug treatment in schizophrenia,” British Journal of Psychiatry, vol. 168, no. 6, pp. 709–717, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Collins, A. Barber, and L. Sahm, “Pharmacist’s counselling improves patient knowledge regarding warfarin, irrespective of health literacy level,” Pharmacy, vol. 2, no. 1, pp. 114–123, 2014. View at Publisher · View at Google Scholar
  7. N. Jarernsiripornkul, N. Chaipichit, P. Chumworathayi, and J. Krska, “Management for improving patients’ knowledge and understanding about drug allergy,” Pharmacy Practice, vol. 13, no. 1, article no. 513, 2015. View at Google Scholar · View at Scopus
  8. CPMS, Clozaril.co.uk, 2015, https://www.clozaril.co.uk.
  9. S. Brosnan, E. Barron, and L. J. Sahm, “Health literacy and the Clozapine patient,” Perspectives in Public Health, vol. 132, no. 1, pp. 39–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Daly and D. Walsh, “Activities of Irish Psychiatric Units and hospitals 2012 main findings,” in Health Research Board Statistics Series 20, Health Research Board, Dublin, Ireland, 2012, http://www.hrb.ie/uploads/tx_hrbpublications/HRB_Statistics_Series_20_Activities_of_Irish_Psychiatric_Units_and_Hospitals_2012__Full_Report__-_Web.pdf. View at Google Scholar
  11. Novartis UK, Clozaril Patient Information Leaflet, 2015, http://www.medicines.ie.
  12. Mistura Enterprise Ltd, Choice and Medication leaflets by subscription, 2015, http://www.choiceandmedication.org.
  13. P. F. Bass III, J. F. Wilson, and C. H. Griffith, “A shortened instrument for literacy screening,” Journal of General Internal Medicine, vol. 18, no. 12, pp. 1036–1038, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Paton and P. Wolfson, “Haematological monitoring for clozapine: do patients know why?” Psychiatric Bulletin, vol. 19, no. 9, pp. 536-537, 1995. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Aleman, R. S. Kahn, and J.-P. Selten, “Sex differences in the risk of schizophrenia: evidence from meta-analysis,” Archives of General Psychiatry, vol. 60, no. 6, pp. 565–571, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. O. D. Howes, F. Vergunst, S. Gee, P. McGuire, S. Kapur, and D. Taylor, “Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation,” The British Journal of Psychiatry, vol. 201, no. 6, pp. 481–485, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. L. J. Sahm, M. S. Wolf, L. M. Curtis, and S. McCarthy, “Prevalence of limited health literacy among irish adults,” Journal of Health Communication, vol. 17, supplement 3, pp. 100–108, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. J. De Leon and F. J. Diaz, “A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors,” Schizophrenia Research, vol. 76, no. 2-3, pp. 135–157, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Farrell, V. French Merkley, and N. Ingar, “Reducing pill burden and helping with medication awareness to improve adherence,” Canadian Pharmacists Journal, vol. 146, no. 5, pp. 262–269, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Rambhade, A. Chakarborty, A. Shrivastava, U. K. Patil, and A. Rambhade, “A survey on polypharmacy and use of inappropriate medications,” Toxicology International, vol. 19, no. 1, pp. 68–73, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Hagger, P. Buckley, J. T. Kenny, L. Friedman, D. Ubogy, and H. Y. Meltzer, “Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine,” Biological Psychiatry, vol. 34, no. 10, pp. 702–712, 1993. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Doyle, K. Cafferkey, and J. Fullam, The European Health Literacy Survey (HLS.EU), 2015, http://vc-health.kums.ac.ir/kums_content/media/image/2013/09/33757_orig.pdf.